Trial
NCT04638517
The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
The University of Queensland
Collaborators
—
Condition
Pulmonary Fibrosis
Intervention
Danazol
Why stopped
Data Safety Monitoring Board recommended cessation due to futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-05